HuGE Literature Finder
Records 1-4
|
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
Molecular oncology 2020 Jun . Hayashi Yujiro, Fujita Kazutoshi, Nojima Satoshi, Tomiyama Eisuke, Matsushita Makoto, Koh Yoko, Nakano Kosuke, Wang Cong, Ishizuya Yu, Kato Taigo, Hatano Koji, Kawashima Atsunari, Ujike Takeshi, Uemura Motohide, Imamura Ryoichi, Morii Eiichi, Nonomura Nor |
|
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
British journal of cancer 2017 Aug 117 (4): 583-587. Descotes Françoise, Kara Norelyakin, Decaussin-Petrucci Myriam, Piaton Eric, Geiguer Florence, Rodriguez-Lafrasse Claire, Terrier Jean E, Lopez Jonathan, Ruffion Ala |
|
Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Apr 27 (4): 516-23. Scott Glynis A, Laughlin Todd S, Rothberg Paul |
|
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Cancer research 2013 Dec 73 (24): 7162-7. Kinde Isaac, Munari Enrico, Faraj Sheila F, Hruban Ralph H, Schoenberg Mark, Bivalacqua Trinity, Allaf Mohamad, Springer Simeon, Wang Yuxuan, Diaz Luis A, Kinzler Kenneth W, Vogelstein Bert, Papadopoulos Nickolas, Netto George |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 22, 2021
- Content source: